Endovia Health Sciences (EDVA) Common Equity (2011 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Common Equity (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 8.42 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 6.76 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 2.61 Bn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 5.17 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 9.79 Bn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -15.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.75 Mn |
| Mar 31, 2026 | -16.20 Mn |
| Dec 31, 2025 | -15.30 Mn |
| Sep 30, 2025 | 22.49 Mn |
| Jun 30, 2025 | -11.28 Mn |
| Mar 31, 2025 | -20.03 Mn |
| Dec 31, 2024 | -18.63 Mn |
| Sep 30, 2024 | -10.83 Mn |
| Jun 30, 2024 | -10.35 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Dec 31, 2023 | -5.61 Mn |
| Sep 30, 2023 | -657,830.00 |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 7.59 Mn |
| Dec 31, 2022 | 9.32 Mn |
| Sep 30, 2022 | 9.99 Mn |
| Jun 30, 2022 | 11.46 Mn |
| Mar 31, 2022 | 14.51 Mn |
| Dec 31, 2021 | 8.87 Mn |
| Sep 30, 2021 | 9.95 Mn |